The World Well being Group has paused the scientific trials of anti-malarial drug hydroxychloroquine in coronavirus sufferers. It says the drug, notably taken and endorsed by US President Donald Trump, has raised security considerations.
The drug’s security information is being reviewed by a monitoring board, and the trials have been placed on maintain, the WHO chief Tedros Adhanom Ghebreyesus informed reporters. It was being examined as a part of the Solidarity worldwide program geared toward tackling the Covid-19 pandemic.
The UN well being physique took the step out of an “abundance of warning,” stated Mike Ryan, the pinnacle of the group’s emergencies program.
Additionally on rt.com
The WHO has beforehand suggested towards the widespread use of the drug in remedy of Covid-19, arguing that it needs to be reserved solely for scientific trials. Nevertheless, it has been actively promoted by Trump, who even took a two-week hydroxychloroquine course as a safety measure towards the coronavirus. In his newest interview revealed Sunday, Trump stated he has completed the course and “continues to be right here.”
DETAILS TO FOLLOW